Full-Time

Senior Scientist

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Accelerates antibody drug discovery with data science

Data & Analytics
AI & Machine Learning
Biotechnology

Senior, Expert

Vancouver, BC, Canada

Requirements
  • You are an innovator and ready to help new approaches to the discovery and development of therapeutics
  • You have a strong desire to support early antibody discovery work by developing ways to improve and speed up the discovery to CMC development to GMP manufacturing paradigm
  • You are ready to revolutionize therapeutic development and move at lightning speed to create a legacy in our industry
  • You are an outstanding communicator and teammate
  • You are highly motivated and excited about the opportunity to work with an inspired team on challenging problems that matter
  • Ph.D. and 5+ years of experience, M.Sc. and 8+ years of experience, or B.Sc. and 10+ years of experience
  • In-depth knowledge of immuno-assay development (Ex. ELISA), troubleshooting, and qualification
  • Familiarity with regulatory requirements as it pertains to CMC activities for monoclonal antibodies (FDA, EMA, ICH, etc)
  • Experience managing and mentoring a team of junior scientists
  • Demonstrated proficiency with molecular biology techniques including 1D-/2D-Gel Electrophoresis, Western blotting, qPCR, etc
  • Proficiency working with data acquisition platforms related to immunoassays (Ex. Softmax Pro)
  • A proven problem-solver and team player with strong written and verbal communication skills
  • Familiarity with electronic lab notebooks (Ex. Benchling), experimental data capture, and the associated 21 CFR part 11 compliance requirements
  • Knowledge of regulatory filings such as INDs, BLAs, IMPDs, etc would be advantageous
  • Understanding of regulatory requirements for biologics
Desired Qualifications
  • Experience with lab automation is a plus
  • Experience with CMC analytical development of monoclonal antibodies or related biotherapeutic proteins is a plus

AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

16%

2 year growth

77%
INACTIVE